NMTR Insider Trading
Insider Ownership Percentage: 2.40%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00
9 Meters Biopharma Share Price & Price History
Current Price: $0.00
Price Change: ▼ Price Decrease of -0.0001 (-100.00%)
As of 12/16/2025 01:00 AM ET
9 Meters Biopharma Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 4/21/2023 | Bethany Sensenig | CFO | Sell | 9,100 | $1.21 | $11,011.00 | 41,077 |  |
9 Meters Biopharma Institutional Trading History
| Reporting Date | Hedge Fund | Shares Held | Market Value | % of Portfolio | Quarterly Change in Shares | Ownership in Company | Details |
|---|
| 2/9/2023 | ODonnell Financial Services LLC | 43,410 | $55K | 0.5% | -95.1% | 0.335% |  |
| 2/7/2023 | Commonwealth Equity Services LLC | 38,141 | $48K | 0.0% | -90.3% | 0.295% | |
| 1/19/2023 | Adviser Investments LLC | 21,429 | $49K | 0.0% | -92.3% | 0.165% | |
| 11/16/2022 | Requisite Capital Management LLC | 300,000 | $65K | 0.0% | N/A | 2.317% | |
| 11/15/2022 | Laurion Capital Management LP | 4,558,200 | $0.98M | 0.0% | +0.1% | 35.198% | |
| 11/14/2022 | Ergoteles LLC | 911,451 | $0.20M | 0.0% | -8.5% | 7.036% | |
| 11/7/2022 | Virtu Financial LLC | 228,595 | $49K | 0.0% | +25.6% | 1.765% | |
| 10/31/2022 | Valeo Financial Advisors LLC | 209,688 | $45K | 0.0% | +5.8% | 1.619% | |
| 8/15/2022 | Laurion Capital Management LP | 4,553,084 | $1.19M | 0.0% | N/A | 1.757% | |
| 8/8/2022 | Curi Wealth Management LLC | 2,072,771 | $0.54M | 0.1% | +17,757.9% | 0.800% | |
| 8/8/2022 | Y Intercept Hong Kong Ltd | 184,315 | $48K | 0.0% | N/A | 0.071% | |
| 7/19/2022 | Commonwealth Equity Services LLC | 290,402 | $75K | 0.0% | +38.0% | 0.112% | |
| 7/14/2022 | Adviser Investments LLC | 286,248 | $75K | 0.0% | +24.0% | 0.110% | |
| 5/11/2022 | GSA Capital Partners LLP | 419,858 | $0.25M | 0.0% | -15.3% | 0.163% | |
| 5/4/2022 | Adviser Investments LLC | 230,888 | $0.14M | 0.0% | +261.0% | 0.089% | |
| 5/4/2022 | Commonwealth Equity Services LLC | 210,402 | $0.13M | 0.0% | +22.3% | 0.081% | |
| 2/16/2022 | Ghost Tree Capital LLC | 3,250,000 | $3.18M | 1.1% | +18.2% | 1.271% | |
| 2/14/2022 | Blair William & Co. IL | 81,912 | $80K | 0.0% | +192.5% | 0.032% | |
| 2/14/2022 | GSA Capital Partners LLP | 495,783 | $0.49M | 0.1% | +3,414.2% | 0.194% | |
| 2/9/2022 | Principal Financial Group Inc. | 68,709 | $67K | 0.0% | -23.0% | 0.027% | |
| 2/8/2022 | ProShare Advisors LLC | 49,462 | $48K | 0.0% | +72.8% | 0.019% | |
| 2/8/2022 | Northern Trust Corp | 2,136,520 | $2.09M | 0.0% | +2.1% | 0.836% | |
| 2/7/2022 | SG Americas Securities LLC | 57,608 | $56K | 0.0% | -46.6% | 0.023% | |
| 1/31/2022 | Commonwealth Equity Services LLC | 172,102 | $0.17M | 0.0% | +12.4% | 0.067% | |
| 1/31/2022 | Adviser Investments LLC | 63,955 | $63K | 0.0% | N/A | 0.025% | |
| 1/25/2022 | J.W. Cole Advisors Inc. | 45,000 | $44K | 0.0% | +50.0% | 0.018% | |
| 11/16/2021 | Schonfeld Strategic Advisors LLC | 39,300 | $51K | 0.0% | N/A | 0.015% | |
| 11/16/2021 | Captrust Financial Advisors | 29,844 | $39K | 0.0% | -74.8% | 0.012% | |
| 11/16/2021 | Two Sigma Securities LLC | 24,834 | $32K | 0.0% | N/A | 0.010% | |
| 11/16/2021 | Metropolitan Life Insurance Co NY | 64,133 | $83K | 0.0% | N/A | 0.025% | |
| 11/12/2021 | Geode Capital Management LLC | 3,624,058 | $4.71M | 0.0% | +7.4% | 1.423% | |
| 11/10/2021 | Mercer Global Advisors Inc. ADV | 60,000 | $78K | 0.0% | N/A | 0.024% | |
| 11/10/2021 | Panagora Asset Management Inc. | 315,867 | $0.41M | 0.0% | N/A | 0.124% | |
| 11/10/2021 | Prentice Wealth Management LLC | 29,000 | $38K | 0.0% | +59.3% | 0.011% | |
| 11/10/2021 | Citigroup Inc. | 27,474 | $36K | 0.0% | +78.3% | 0.011% | |
| 11/9/2021 | BlackRock Inc. | 13,566,265 | $17.64M | 0.0% | +0.6% | 5.325% | |
| 11/9/2021 | Boston Private Wealth LLC | 26,000 | $34K | 0.0% | N/A | 0.010% | |
| 11/8/2021 | State Board of Administration of Florida Retirement System | 52,330 | $68K | 0.0% | N/A | 0.021% | |
| 11/5/2021 | Advisor Group Holdings Inc. | 62,547 | $81K | 0.0% | +84.0% | 0.025% | |
| 11/4/2021 | Almanack Investment Partners LLC. | 40,850 | $53K | 0.0% | -21.7% | 0.016% | |
| 11/4/2021 | Deutsche Bank AG | 1,078,613 | $1.40M | 0.0% | -65.9% | 0.423% | |
| 11/2/2021 | New York State Common Retirement Fund | 103,586 | $0.14M | 0.0% | -43.1% | 0.041% | |
| 11/1/2021 | SG Americas Securities LLC | 107,970 | $0.14M | 0.0% | +292.0% | 0.042% | |
| 10/29/2021 | Commonwealth Equity Services LLC | 153,052 | $0.20M | 0.0% | +101.4% | 0.060% | |
Data available starting January 2016
9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders in North America. Its lead product candidate is Vurolenatide, a long-acting injectable glucagon-like-peptide-1 that is in Phase 3 clinical trial to treat short bowel syndrome. The company is developing NM-136, a humanized monoclonal antibody for the treatment of obesity and obesity-related disorders; NM-102, a small molecule peptide to prevent antigens from trafficking into systemic circulation; and NM-003, a proprietary long-acting glucagon-like peptide-2 receptor agonist for prevention of acute graft versus host disease. Its partnered product is Larazotide, an 8-amino acid peptide, which is in Phase 2 clinical trial for treatment of multi-system inflammatory syndrome. The company has licensing agreements with Amunix, MHS Care Innovation LLC, Alba Therapeutics Corporation, and EBRIS. 9 Meters Biopharma, Inc. is headquartered in Raleigh, North Carolina. On July 17, 2023, 9 Meters Biopharma, Inc. filed a voluntary petition for liquidation under Chapter 7 in the U.S. Bankruptcy Court for the Eastern District of North Carolina.
Read More on 9 Meters Biopharma
Today's Range
Now: N/A
50 Day Range
MA: N/A
52 Week Range
Now: N/A
Volume
164 shs
Average Volume
315,915 shs
Market Capitalization
$1.04 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.36
